More News

28 Oct 2019 Molecular Targeting Technologies, Inc. Receives Global Rights From NIH for Integrin-Targeting Radiotherapeutics to Treat GBM and Lung Cancer
26 Oct 2019 AbbVie Announces Collaboration with Cystic Fibrosis Foundation
23 Oct 2019 Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
23 Oct 2019 Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates
22 Oct 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
22 Oct 2019 Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
21 Oct 2019 Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
21 Oct 2019 pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology
21 Oct 2019 CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
16 Oct 2019 Alexion to Acquire Achillion
16 Oct 2019 Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases
16 Oct 2019 Ipsen and Blueprint Medicines Announce Exclusive Global License Agreement to Develop and Commercialize BLU-782 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
15 Oct 2019 CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
11 Oct 2019 Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.
10 Oct 2019 Alexion and Stealth Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases
10 Oct 2019 Bayer and RIKEN Innovation establish partnership in drug discovery
10 Oct 2019 Avacta Group plc Enters Collaboration and Option Agreement With ADC Therapeutics
10 Oct 2019 UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases
09 Oct 2019 bluebird bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases
08 Oct 2019 GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
08 Oct 2019 Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
08 Oct 2019 4D Pharma Collaborates With MSD to Develop Live Biotherapeutics for Vaccines
07 Oct 2019 Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx
04 Oct 2019 Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases
02 Oct 2019 Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up